Mpox Disease Transmission, Clinical Presentation and Prevention : Article Review
DOI:
https://doi.org/10.46966/msjar.v6i2.270Keywords:
Clinical Presentation and prevention, Mpox disease transmission,, MopxAbstract
"Mpox one of zoonotic disease"(WHO), in 1958 are first discovered monkeys , the viruse that responsible of these disease belong to the genus Orthopoxvirus , a member of the Poxviridae family. It gained significant attention in the 1970s when first cases for human were recorded, particularly in Central, West Africa.The spread of recent outside these endemic areas has raised global concerns. This article discusses monkeypox, its clinical features, and prevention strategies. Direct contact with infected animals causes transmission to humans. transmitted of virus from person to person by respiratory droplets, skin attached , and sexually. The fever, swollen lymph nodes consider most common symptoms in monkeypox patients also rash that progresses through many stages before recovery.
The immunocompromised individuals experience complications like secondary bacterial infection and severe systemic problems. Although there is no specific cure, antiviral like tecovirimat and supportive care have shown promising results. Vaccination remains a critical preventive measure, especially for the most vulnerable groups. Understanding the epidemiology, pathogenesis, and effective control strategies is essential to mitigate the global impact of viral infection.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zainab Mohammed Madfoon

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















